New WHO guidelines for influenza B/Yamagata strain vaccine

  • Thread starter Laroxe
  • Start date
In summary, the World Health Organization (WHO) has issued new guidelines for the formulation of influenza vaccines targeting the B/Yamagata strain. These guidelines emphasize the importance of including the B/Yamagata lineage in quadrivalent vaccines to enhance protection against seasonal influenza. The recommendations aim to improve efficacy and public health outcomes, encouraging countries to adopt these guidelines in their vaccination programs to better manage influenza outbreaks.
  • #1
Laroxe
Science Advisor
613
807
The latest ed. of The Lancet (Infectious Diseases) reports on the new WHO guidelines on the influenza vaccine. They now recommend that the quadrivalent vaccine should no longer contain the influenza B/Yamagata strain as it is no longer being detected in circulation. It's suggested that the non pharma logical interventions introduced for Covid 19 may have effectively stopped the wild type virus spreading. They say, "This would represent the first time that an influenza virus has been eliminated from the human population through NPIs."

The edition also discusses developments in searching for a universal influenza vaccine.
They also report on the effectiveness of the monovalent Covid 19 vaccines, suggesting they are less effective than the older bivalent formulations, there is also so info on cost effectiveness of vaccination.

Remember you can sign up for free (limited) access to the Lancet.

https://doi.org/10.1016/S1473-3099(23)00366-3
https://doi.org/10.1016/S1473-3099(23)00697-7
https://doi.org/10.1016/S1473-3099(23)00424-3
 
  • Like
  • Informative
Likes Greg Bernhardt, sbrothy, pinball1970 and 4 others
Biology news on Phys.org
  • #3
Greg Bernhardt said:
How common is it for viral strains to go extinct?
Well, we know it happens, but I doubt we will ever know how often. Really the only virus we know much about are those that cause diseases in humans and their food sources. The chances of a virus becoming extinct is heavily dependent on its hosts, and its effects on the hosts. A virus with a wide range of hosts, that is easily transmitted and has access to a non-immune population is unlikely to fail. There is however some interesting historical evidence of diseases and virus that have simply disappeared. We have encouraged the extinction of smallpox, rinderpest, and most recently SARS and there are others being targeted but its very difficult.

I suppose we could assume that extinctions happening naturally are rare but there is such a vast number of different species, who knows. The extinction of other living species, might in fact take several populations of virus with them, but evolution in virus can happen very quickly and that doesn't seem rare at all.
 
  • Like
Likes pinball1970, BillTre and Greg Bernhardt

FAQ: New WHO guidelines for influenza B/Yamagata strain vaccine

What are the new WHO guidelines for the influenza B/Yamagata strain vaccine?

The new WHO guidelines for the influenza B/Yamagata strain vaccine emphasize the importance of including the Yamagata lineage in seasonal influenza vaccines. These guidelines are based on recent epidemiological data and aim to enhance the effectiveness of vaccines by ensuring they provide adequate protection against circulating strains.

Why is the Yamagata strain important in influenza vaccines?

The Yamagata strain is one of the two lineages of the influenza B virus. It has been associated with significant seasonal outbreaks and can lead to severe illness. Including the Yamagata strain in vaccines is crucial for providing comprehensive protection against influenza B infections, which can affect various populations, particularly children and the elderly.

How often do the WHO guidelines for influenza vaccines change?

The WHO guidelines for influenza vaccines are reviewed and updated annually based on the latest surveillance data, research findings, and trends in circulating strains. This process ensures that vaccines remain effective against the most prevalent strains each flu season.

What impact do the new guidelines have on vaccine manufacturers?

The new guidelines require vaccine manufacturers to adjust their formulations to include the Yamagata strain, ensuring that their products comply with WHO recommendations. This may involve changes in production processes, testing, and regulatory submissions to ensure the vaccines meet safety and efficacy standards.

How can the public stay informed about changes in influenza vaccination guidelines?

The public can stay informed about changes in influenza vaccination guidelines through various channels, including the WHO website, public health department announcements, and healthcare provider communications. Additionally, following reputable health organizations on social media can provide timely updates and information regarding vaccination recommendations.

Similar threads

Replies
6
Views
2K
Replies
2
Views
1K
Replies
6
Views
2K
Replies
22
Views
3K
Replies
4
Views
1K
Replies
516
Views
32K
Back
Top